Clinical Trial Finder
Blaze a trail to better treatments and a cure for cystic fibrosis.
Clinical trials that test potential drugs and therapies in people with cystic fibrosis are a major part of CF research. They take place at Cystic Fibrosis Foundation-accredited care centers all over the United States and enroll people with CF of all ages.
Nothing is more important than patient safety in developing new treatments for cystic fibrosis. The U.S. government requires that all clinical trials are supervised for safety, and the Cystic Fibrosis Foundation adds additional measures to protect study volunteers.
The following is a collection of information and news about Trikafta®, the triple-combination modulator therapy that was approved by the U.S. Food and Drug Administration on Oct. 21, 2019.